These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18 related articles for article (PubMed ID: 19797940)
1. Relationship between pharmaceutical company user fees and drug approvals in Canada and Australia: a hypothesis-generating study. Lexchin J Ann Pharmacother; 2006 Dec; 40(12):2216-22. PubMed ID: 17132811 [TBL] [Abstract][Full Text] [Related]
2. User-fee bill passes US Senate, but legislative hurdles remain. Fox JL Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086 [No Abstract] [Full Text] [Related]
3. FDA user fees approved. Clin Pharm; 1993 Jan; 12(1):3. PubMed ID: 8428431 [No Abstract] [Full Text] [Related]
4. User fees advance in Congress. Gershon D Nature; 1992 Sep; 359(6393):261. PubMed ID: 1406918 [No Abstract] [Full Text] [Related]
5. FDA user fees and innovation. Somberg J Am J Ther; 2008; 15(2):97. PubMed ID: 18356626 [No Abstract] [Full Text] [Related]
6. Pharmaceutical company user fees: their uses and abuses. Miller HI Am J Ther; 2009; 16(6):475-6. PubMed ID: 19797940 [No Abstract] [Full Text] [Related]
7. AIDS drugs & the pharmaceutical industry: a need for reform. Griffin MT Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767 [TBL] [Abstract][Full Text] [Related]
8. A discussion of pharmaceutical industry practices viewed as illegal by the federal government. Nino K Health Care Law Mon; 1999 Nov; ():8-16. PubMed ID: 11067433 [No Abstract] [Full Text] [Related]